Pancreatic Cancer Research

ResearcherParker Institute for Cancer ImmunotherapyActive in the last 2 years

Carl H. June

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0241-3557; OpenAlex author ID A5008558372; NIH RePORTER profile ID 1970082. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
2
Labs led
1
Collaborators
20
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 grant · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper, 1 grant

Papers 5

  1. Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancrea… Co-author DOI 10.3389/fimmu.2026.1805950↗
  2. Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2025.102301↗
  3. Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer. Co-author DOI 10.1073/pnas.2403002121↗
  4. Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer. Co-author DOI 10.1016/j.ymthe.2020.07.017↗
  5. Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses. Last author DOI 10.1172/jci.insight.99573↗

Grants 2

  1. Precision UCART and Nanoparticle Combination to Combat Hostile Microenvironments (PUNCH) R01CA316019↗
  2. Directing the metabolic fate of CAR T cells R01CA226983↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Don L. Siegel · 2 shared papers, 2025–2026 · strength 0.45
  2. John Scholler · 2 shared papers, 2018–2026 · strength 0.35
  3. Gabriela Plesa · 2 shared papers, 2020–2025 · strength 0.26
  4. Mark H. O’Hara · 2 shared papers, 2020–2025 · strength 0.26
  5. Constantinos Koumenis Nahum · 1 shared paper, 2024 · strength 0.19
  6. Uri Amit · 1 shared paper, 2024 · strength 0.19
  7. Edgar Ben‐Josef · 1 shared paper, 2024 · strength 0.19
  8. Andrew J. Rech · 1 shared paper, 2025 · strength 0.17
  9. Andrew Haas · 1 shared paper, 2025 · strength 0.17
  10. Joseph A. Fraietta · 1 shared paper, 2025 · strength 0.17
  11. Janos Laszlo Tanyi · 1 shared paper, 2025 · strength 0.17
  12. Maria Angela Aznar · 1 shared paper, 2025 · strength 0.17
  13. Hua Huang · 1 shared paper, 2025 · strength 0.17
  14. Andrew H. Ko · 1 shared paper, 2020 · strength 0.09
  15. Lawrence H. Fong · 1 shared paper, 2020 · strength 0.09
  16. Alan Paul Venook · 1 shared paper, 2020 · strength 0.09
  17. Margaret A. Tempero · 1 shared paper, 2020 · strength 0.09
  18. Gregory Lawrence Beatty · 1 shared paper, 2020 · strength 0.09
  19. Akseli Hemminki · 1 shared paper, 2018 · strength 0.07
  20. Keisuke Watanabe · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.